Want to stay on top of the science and politics driving biotech today? Sign up t...
The FDA disclosed safety concerns about a CRISPR-based treatment for sickle cell...
A large increase in greenhouse gas emissions would lead to a 233% increase in ex...
Direct-to-consumer telehealth options are proliferating for low-complexity visit...
In the next few weeks, Sarepta Therapeutics will release new data that could cha...
A marijuana black market became a multibillion-dollar driver of Colorado's econo...
Just as hospitals’ contract labor problem eases, another is taking its place: ph...
Outgoing Bristol CEO Giovanni Caforio sat for an exit interview with @matthewher...
Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting.
The Senate Finance Committee plans to move ahead with a wide-ranging health care...
The Biden administration is slowly shifting millions of Covid-19 treatments to p...
LEO-152020 is under clinical development by Leo Pharma and currently in Phase II...
Osemitamab is under clinical development by Transcenta and currently in Phase II...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
